Kyverna Therapeutics, Inc Common Stock

Price & Volume

Stats

52W Range	$3.22-$35.06
Market Cap	$143.7M
Shares Short	2M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	-$96.1M
Diluted EPS	-$2.96

News

Yahoo Finance • 12 hours ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, DMC Global, and Marqeta and Encourages Investors to Contact the Firm

Yahoo Finance • 20 hours ago

Investors who lost money on Kyverna Therapeutics, Inc.(KYTX) should contact The Gross Law Firm about pending Class Action - KYTX

Yahoo Finance • 23 hours ago

KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline

Yahoo Finance • 2 days ago

ROSEN, A LEADING LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX

About

CEO	Mr. Warner Biddle
Address	5980 Horton Street, Emeryville, CA, United States, 94608
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	96